StockNews.com upgraded shares of FONAR (NASDAQ:FONR – Free Report) from a buy rating to a strong-buy rating in a research note released on Wednesday.
FONAR Stock Down 2.3 %
Shares of FONR opened at $18.00 on Wednesday. The stock has a 50 day moving average price of $16.38 and a 200 day moving average price of $18.40. The company has a market capitalization of $113.94 million, a price-to-earnings ratio of 11.54 and a beta of 1.19. FONAR has a 52-week low of $12.13 and a 52-week high of $24.05.
FONAR (NASDAQ:FONR – Get Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The medical equipment provider reported $0.27 earnings per share for the quarter. FONAR had a return on equity of 7.50% and a net margin of 10.66%. The company had revenue of $25.72 million during the quarter.
Institutional Investors Weigh In On FONAR
FONAR Company Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Featured Stories
- Five stocks we like better than FONAR
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- How to Read Stock Charts for Beginners
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.